These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7049441)

  • 1. Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy.
    Engler R; Pouleur H; Link J; Printz M; Covell JW
    Clin Exp Hypertens A; 1982; 4(4-5):639-59. PubMed ID: 7049441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload.
    Pouleur H; Engler RL; Link J; Printz MP; Covell JW
    Eur J Clin Invest; 1983 Aug; 13(4):331-8. PubMed ID: 6413220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
    Sim MF; Yates DB; Parkinson R; Cooling MJ
    Br J Pharmacol; 1988 Jun; 94(2):371-80. PubMed ID: 3293682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator and inotropic therapy of heart failure [panel discussion].
    Am J Med; 1978 Jul; 65(1):208-16. PubMed ID: 685996
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of repeated administration of prazosin on its hypotensive effect and on renin release in conscious dogs. A comparison with urapidil.
    Beck A; Kraupp O; Bacher S; Seitelberger R; Raberger G
    Basic Res Cardiol; 1984; 79(5):579-87. PubMed ID: 6391463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of adrenergic nervous and prostaglandin systems on hydralazine-induced renin release.
    Sinaiko AR
    Life Sci; 1983 Dec; 33(23):2269-75. PubMed ID: 6316059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
    Ribner HS; Bresnahan D; Hsieh AM; Silverman R; Tommaso C; Coath A; Askenazi J
    Prog Cardiovasc Dis; 1982; 25(1):1-42. PubMed ID: 6287524
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afterload reduction in the treatment of cardiac failure.
    Mason DT
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure.
    Franciosa JA
    Prog Cardiovasc Dis; 1982; 24(4):319-30. PubMed ID: 7034048
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M; Medina N; Yushak M
    Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin does not alter canine renin release in response to systemic hypotension or intrarenal isoprenaline and prostaglandin I2 infusion.
    Gerber JG; Nies AS; Olson RD
    Br J Pharmacol; 1980; 71(2):533-7. PubMed ID: 7008886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
    Chatterjee K; Parmley WW
    J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central effects of caffeine on renal renin secretion and norepinephrine spillover.
    Tofovic SP; Kusaka H; Pfeifer CA; Jackson EK
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):302-13. PubMed ID: 8856488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine potentiates vasodilator-induced renin release.
    Tofovic SP; Branch KR; Oliver RD; Magee WD; Jackson EK
    J Pharmacol Exp Ther; 1991 Mar; 256(3):850-60. PubMed ID: 2005584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.